Apart from epigenetics, we should not lose sight of the fact that metabolic syndrome, insulin resistance, obesity, and inflammation, importantly interrelated conditions in which PPARG has modifying and regulatory actions, increase cancer risk [52–59], which adds weight to PPARG and cancer research (Figure 1). Here, PPARG is linked to cancer.